if the compound cannot find a practical use the company is at or above fair value. if it can not be commercialised it is worthless.
sure it inhibits biofilm formation, but if the compound is not compatible with materials/environments where biofilms form then its use is limited.
i hope it turns around. i bought in above 15c. i liked the story because i work in medicine. however i am not optimistic about the fundamental outlook.
- Forums
- ASX - By Stock
- BOS
- whats the outlook
whats the outlook, page-13
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)